Aminotadalafil Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Aminotadalafil dosing — protocols, safety, and where to buy.
Dose Range
2.5 mg - 20 mg (oral)
Dosage Calculator
Calculate exact dosing for Aminotadalafil.
Dosing Protocols
The beginner protocol for aminotadalafil is: do not use it. Use prescription tadalafil instead.
That is not a rhetorical flourish — it is the correct medical and legal guidance. Here is why, and what to do instead:
Why not aminotadalafil:
- Generic tadalafil is available by prescription in virtually every developed country at very low cost (often under $1 per dose for generic 10 mg or 20 mg tablets through insurance or cash-pay telehealth services).
- Tadalafil has regulatory approval, manufacturing quality standards, and decades of safety data.
- Aminotadalafil has none of those things, and is typically encountered as an adulterant in supplements where the actual dose is unknown and variable.
- Using aminotadalafil instead of tadalafil is accepting unknown unknowns for no corresponding benefit.
What a beginner erectile-dysfunction protocol actually looks like:
-
Medical evaluation. ED can be an early sign of cardiovascular disease, diabetes, hypogonadism, or depression. See a primary care clinician or a legitimate telehealth ED service. Baseline labs typically include fasting glucose/A1c, lipid panel, total and free testosterone, complete blood count, comprehensive metabolic panel, TSH, and PSA (for men over 40).
-
Lifestyle foundation. Weight management, smoking cessation, alcohol moderation, cardiovascular exercise, and sleep optimization all improve erectile function measurably within weeks to months. These foundational interventions are the most durable ED treatment available.
-
If PDE5 inhibitor is indicated, a legitimate clinician will typically start with:
- Tadalafil 10 mg as-needed, taken 30–60 minutes before anticipated activity, OR
- Tadalafil 5 mg daily, for users with frequent activity or concurrent benign prostatic hyperplasia
- Sildenafil 50 mg as-needed as an alternative with different pharmacokinetics
- Dose adjustment based on response and tolerability
-
Monitoring. Response, side effects (headache, flushing, dyspepsia, back pain), and any visual or auditory changes should be tracked and reported.
If a reader has already obtained aminotadalafil and insists on engaging with it — against all guidance — the research-community low-end dose referenced is typically 5–10 mg oral, with the same as-needed timing framework as tadalafil, and with full acknowledgment that the actual dose delivered depends on the purity and content uniformity of the source material, which in virtually all gray-market supplies is not verified.
The pragmatic beginner action is: do not engage with this compound recreationally or as a supplement. If you need a PDE5 inhibitor, get a prescription.
An "intermediate protocol" for aminotadalafil in a responsible framing does not exist because the compound is not an approved or characterized therapy. What follows is guidance for readers who have already committed to PDE5 inhibitor use, with the strong recommendation that they do so through legitimate tadalafil rather than aminotadalafil.
Intermediate PDE5 inhibitor use framework (applies to legitimate tadalafil, not aminotadalafil):
Dosing approaches:
- As-needed dosing: Tadalafil 10–20 mg taken 30 minutes to 24 hours before activity; long half-life (~17.5 hours) provides a "weekend" window of activity that distinguishes it from sildenafil.
- Daily low-dose: Tadalafil 2.5–5 mg daily. Useful for men with frequent activity, concurrent benign prostatic hyperplasia, or those who prefer not to associate medication timing with sexual activity. Daily dosing also has some evidence of improving endothelial function and spontaneous nocturnal erections.
- Combination evaluation: concurrent testosterone replacement, SSRI adjustment (some SSRIs cause ED), and management of diabetes or hypertension are often essential for adequate response.
Intermediate monitoring:
- Blood pressure and pulse at baseline and periodically during therapy
- Vision and hearing changes tracked subjectively
- Lipids and metabolic markers on the usual cardiovascular risk monitoring schedule
- Testosterone annually if on TRT
- Re-evaluation if ED symptoms change despite therapy (may reflect progression of vascular disease)
Combining with other vascular health strategies:
- Aerobic exercise 150+ minutes per week
- Resistance training 2–3x weekly
- Mediterranean-pattern dietary approach
- Weight management targeting healthy BMI and waist circumference
- Sleep optimization — sleep apnea is strongly linked to ED
- Stress management and relationship counseling where relevant
Where aminotadalafil specifically comes up at this level: almost always as an accidental exposure through a supplement marketed as "all-natural performance enhancement," or through a research-chemical purchase by a user seeking to experiment. In both cases, the appropriate intermediate-user response is:
- Stop the adulterated supplement or gray-market source.
- See a clinician for a legitimate ED workup.
- Begin prescription tadalafil or sildenafil as indicated.
- Investigate any reported adverse events that may have been caused by the unknown exposure.
Specific red flags at the intermediate level:
- Headaches, flushing, or back pain that appeared after starting a "natural" supplement — likely an adulterated product
- Unexpected interactions with nitrates, alpha-blockers, or alcohol while using supplements
- Persistent visual changes or sudden hearing changes — stop all PDE5i-class compounds and seek medical evaluation
- Priapism — urologic emergency regardless of which PDE5i caused it
The intermediate takeaway is exactly the same as the beginner takeaway: if the goal is PDE5 inhibition for sexual or vascular reasons, generic tadalafil is the correct compound, obtained through a legitimate medical channel. Aminotadalafil adds risk without adding benefit.
Advanced users in the PDE5 inhibitor space are typically men managing erectile dysfunction in the context of broader cardiovascular and metabolic disease, or men using PDE5 inhibitors for off-label purposes such as performance in endurance sport, altitude adaptation, or management of Raynaud's phenomenon. At the advanced level, the distinction between "legitimate pharmacology" and "research chemical" matters enormously, and aminotadalafil remains on the wrong side of that line.
Advanced legitimate PDE5i applications:
- Daily low-dose tadalafil for combined ED and BPH — 5 mg daily; well-supported by multiple large RCTs
- PDE5i for Raynaud's phenomenon — off-label but supported by published trials; reduces digital ischemic attacks
- PDE5i in pulmonary arterial hypertension — a specific indication for tadalafil (Adcirca) and sildenafil (Revatio); managed by specialists
- PDE5i + alpha-blocker combinations for BPH-predominant LUTS — carefully dose-separated; improves symptom scores
- PDE5i + testosterone in hypogonadal men with ED — frequently necessary combination; each component addresses a different mechanism
- Off-label investigation of PDE5i for altitude-associated pulmonary edema (HAPE) — some evidence for prophylactic tadalafil at altitude; not standard of care but described in high-altitude medicine literature
Advanced monitoring at this level:
- Echocardiography if pulmonary hypertension is in the differential
- Stress testing for cardiovascular risk stratification
- Continuous glucose monitoring or frequent A1c in diabetic men
- Formal hormonal panel including LH, FSH, estradiol, SHBG, DHT if TRT is combined
- Ophthalmologic evaluation if any visual changes
- Audiometry if any auditory changes
Advanced combinations to approach carefully:
- PDE5i + TRT (commonly appropriate, requires monitoring)
- PDE5i + semaglutide or tirzepatide (often appropriate; address both metabolic and vascular drivers of ED)
- PDE5i + metformin and other metabolic interventions (synergistic; metabolic health improves ED)
- PDE5i + cardiovascular pharmacotherapy (ACE inhibitors, ARBs, statins) — generally compatible
- PDE5i + antidepressants — choose agents with lower ED burden (bupropion, vortioxetine) where possible
- PDE5i + alpha-blockers — feasible with careful dose separation
Advanced combinations to avoid:
- Multiple PDE5 inhibitors simultaneously
- PDE5i + nitrates (absolute contraindication)
- PDE5i + recreational nitrates (absolute contraindication)
- PDE5i + unverified "male-enhancement" supplements (high risk of adulterant interaction with known drugs)
- PDE5i from gray-market or research-chemical sources at any dose
Where aminotadalafil specifically fits at the advanced level: it does not. At no point does a sophisticated clinician or experienced user choose aminotadalafil over legitimate tadalafil. The compound's existence in the body-hacking conversation is primarily as a cautionary tale about supplement adulteration and as a forensic-chemistry reference.
Advanced framing of the overall space:
- Chronic ED is a cardiovascular disease marker. Treat the underlying disease aggressively.
- Chronic use of low-dose tadalafil has plausible endothelial-function benefits beyond ED itself.
- Testosterone deficiency contributes to a meaningful fraction of ED cases and must be evaluated.
- Relationship, psychological, and sleep factors deserve attention alongside pharmacotherapy.
- Never sacrifice regulatory oversight for convenience — the supply chain matters, especially for chronic-use medications.
For readers optimizing across the broader body-hacking space, metabolic optimization, mitochondrial support, vascular rejuvenation strategies, and cardiovascular training protocols are the foundational pillars. PDE5 inhibitors are a legitimate piece of that stack when sourced through legitimate channels — but that means tadalafil, not aminotadalafil.
Commonly Stacked With
Aminotadalafil is not a compound that rewards stacking creativity. Its entire pharmacologic value is as a PDE5 inhibitor, and the same approved-drug alternatives (tadalafil, sildenafil, avanafil, vardenafil) deliver the same effect with regulatory oversight and dosing precision. Any "stack" involving aminotadalafil is effectively a stack involving tadalafil with extra unknowns.
The only stacking relationships worth noting are negative interactions:
Catastrophic combinations — do not stack:
- Nitrates (nitroglycerin, isosorbide mononitrate/dinitrate, amyl nitrite / "poppers") — the combination produces life-threatening hypotension. This is the single most important drug interaction in PDE5 inhibitor pharmacology.
- Alpha blockers (tamsulosin, doxazosin, terazosin) at high doses — additive hypotension; PDE5i can be used with alpha blockers but only with careful dose separation and blood pressure monitoring.
- Strong CYP3A4 inhibitors (ritonavir, ketoconazole, itraconazole, clarithromycin, grapefruit juice in very high amounts) — increase PDE5i plasma levels dramatically, increasing side-effect and adverse-event risk.
- Recreational stimulants + PDE5i + vasodilator combinations — MDMA, amyl nitrite, and cocaine in combination with PDE5i create cardiovascular stress patterns associated with serious events.
Stacks sometimes discussed in male-enhancement supplement contexts:
- L-arginine and L-citrulline — NO precursors, theoretically synergistic with PDE5 inhibition; generally tolerated.
- Icariin and other "herbal PDE5 inhibitors" — often the "herbal" effect is just the adulterant aminotadalafil; genuine icariin has weak PDE5-inhibitory activity.
- Testosterone replacement therapy — reasonable when hypogonadism and ED coexist; prescribed independently of aminotadalafil.
- Vascular support stacks (L-carnitine, CoQ10, omega-3 fatty acids) — generally safe and supportive of endothelial function.
Do not stack with:
- Other PDE5 inhibitors (tadalafil + sildenafil, etc.) — additive side effects, no clinical benefit
- Amyl nitrite or other "poppers" — covered above, life-threatening
- Unknown-origin bulk research chemicals — you cannot stack unknowns safely
- Performance-enhancing compounds stacks that include vasodilators — unpredictable cumulative effects
The honest stacking advice for readers interested in optimizing sexual health:
- Verify testosterone status with labs; address hypogonadism through legitimate TRT if indicated
- Optimize cardiovascular health — ED is often an early cardiovascular disease marker
- Address metabolic health — type 2 diabetes, obesity, and metabolic syndrome are major ED contributors
- Consider prescription tadalafil or sildenafil from a legitimate prescriber if lifestyle optimization is insufficient
- Do not use adulterated supplements or research-chemical PDE5 inhibitors
For readers focused on the broader domain of metabolic and vascular optimization, the full body-hacking protocol library addresses cardiovascular risk factors that predispose to ED far more durably than any PDE5 inhibitor does.
Side Effects & Safety
Contraindications
**Absolute contraindications to aminotadalafil (and all PDE5 inhibitors):** - Concurrent nitrate therapy — nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite, or any nitrate donor. The combination can cause life-threatening hypotension. - Recent myocardial infarction (within 90 days) or unstable angina - Severe heart failure (NYHA class III–IV) - Severe hypotension (systolic BP below 90 mmHg) or uncontrolled hypertension (systolic BP above 170 mmHg) - Recent stroke (within 6 months) - History of non-arteritic anterior ischemic optic neuropathy (NAION) — PDE5i use is associated with recurrence - Severe hepatic impairment (Child-Pugh C) - Retinitis pigmentosa - Known hypersensitivity to tadalafil or related compounds - Use with guanylate cyclase stimulators (riociguat) — pulmonary hypertension drug; combination causes severe hypotension - Pediatric use — not appropriate **Absolute contraindication specific to aminotadalafil (beyond the class):** - Any situation in which regulatory oversight, manufacturing quality, and dose accuracy matter. This effectively means aminotadalafil should not be used in any legitimate medical scenario. **Relative contraindications requiring medical oversight:** - Concurrent alpha-blocker therapy for BPH or hypertension (tamsulosin, doxazosin, etc.) — dose separation required - Strong CYP3A4 inhibitor use (ritonavir, ketoconazole, itraconazole, clarithromycin, certain HIV antivirals) — dose reduction required - Moderate hepatic or renal impairment — dose adjustment required - Anatomic deformities of the penis (Peyronie's disease, severe fibrosis) — increased priapism risk - Sickle cell disease, multiple myeloma, leukemia — increased priapism risk - Bleeding diatheses or active peptic ulcer — PDE5i can increase bleeding risk - Concurrent alcohol use in large amounts - History of NAION in one eye — at high risk of the other eye - Men using concurrent SSRIs for premature ejaculation — usually manageable but monitor for cumulative sexual dysfunction **Drug interactions:** - Nitrates — absolute contraindication - Guanylate cyclase stimulators (riociguat) — absolute contraindication - Alpha-blockers — dose separation and caution - CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin, grapefruit juice in very large quantities) — dose reduction - CYP3A4 inducers (rifampin, phenytoin, carbamazepine, St. John's wort) — reduced PDE5i efficacy - Antihypertensive agents (ACE inhibitors, ARBs, calcium channel blockers, beta-blockers, diuretics) — additive hypotension, generally manageable with routine monitoring - Other PDE5 inhibitors — do not combine **Populations requiring specialist evaluation before any PDE5i use:** - Men with known cardiovascular disease, including CAD and heart failure - Men with pulmonary arterial hypertension (specialist-managed) - Men on complex antihypertensive regimens - Men with hepatic or renal impairment - Men with a history of priapism from any cause - Transplant recipients on CYP3A4-affecting immunosuppressants - Older men with multiple comorbidities **Baseline evaluation before beginning any PDE5i therapy:** - Full cardiovascular history and examination - Blood pressure at rest and with positional change - Current medication review, especially for nitrates and alpha-blockers - Review of visual and auditory history - Lipid profile, fasting glucose, A1c, basic metabolic panel - Testosterone (total and free) — hypogonadism frequently co-occurs with ED - Review of psychological and relationship factors **Monitoring during PDE5i therapy:** - Response — erectile function improvement, side effects - Blood pressure if on antihypertensives or alpha-blockers - New vision or hearing symptoms — stop immediately if they occur - New chest pain or exercise intolerance — stop and evaluate - Annual cardiovascular risk reassessment **The bottom line on contraindications:** treat aminotadalafil's contraindication list as at least as strict as tadalafil's, with an additional implicit contraindication for the compound being an unapproved, unregulated, adulterated-supplement-associated material. For any reader with a legitimate medical indication, use prescription tadalafil from a legitimate prescriber and abandon aminotadalafil entirely.
Additional Notes
Aminotadalafil does not have an established consumer dosing regimen because it is not an approved drug. The dose ranges that appear in research-community discussions are extrapolated from tadalafil and from the content analyses of adulterated supplement products.
For reference — approved tadalafil dosing (the correct alternative):
- As-needed ED dosing: 10 mg orally before anticipated activity; may increase to 20 mg or decrease to 5 mg based on response and tolerability.
- Daily ED and BPH dosing: 2.5–5 mg orally once daily.
- Pulmonary arterial hypertension: 40 mg orally once daily.
For reference — levels of aminotadalafil typically found in adulterated supplements:
- Analyses of seized product capsules have shown aminotadalafil content ranging from undetectable to over 100 mg per capsule, often in products marketed as "all-natural" and containing no PDE5 inhibitor disclosure. Dose consistency between capsules in the same bottle has been documented to vary by 10-fold or more.
- Bulk research-chemical aminotadalafil is typically sold as powder with a claimed purity that is rarely verified.
Important dosing-adjacent considerations:
- Timing: tadalafil and (by extension) aminotadalafil work over an extended window — effect begins in roughly 30 minutes and persists for up to 36 hours due to the long half-life.
- Food effects: tadalafil absorption is not materially affected by food. Sildenafil is significantly delayed by high-fat meals, so for as-needed use, timing relative to meals differs between these agents.
- Alcohol: moderate amounts are generally tolerated; large amounts can cause orthostatic hypotension and compromise erectile function independent of pharmacology.
- Drug interactions: dose reductions are required for PDE5 inhibitors in patients taking strong CYP3A4 inhibitors. Dose caps of 10 mg tadalafil per 72 hours are typical in patients on ritonavir. These cautions transfer directly to aminotadalafil with additional uncertainty about metabolism.
- Renal and hepatic adjustment: tadalafil dose is capped in severe renal impairment and in hepatic impairment. Aminotadalafil would follow the same framework, but no formal guidance exists.
A critical note on "stacking PDE5 inhibitors" in supplements: Adulterated products have been documented to contain aminotadalafil plus sildenafil, plus another PDE5 analog, creating unknown cumulative doses. Users consuming such products have reported PDE5 inhibitor effects far exceeding what the product label would suggest, and occasional severe adverse events.
What to do instead: If erectile function or vascular support is the goal, the correct action is to get a prescription for generic tadalafil or sildenafil through a legitimate clinician or telehealth service. The cost is low, the dosing is standardized, the manufacturing is regulated, and the drug interactions are understood. For the broader question of sexual health and vascular optimization, see protocols across /compounds and /stack.
Where to Buy Aminotadalafil
Compare 1 listing across 1 vendor — from $54.00
Frequently Asked Questions
What is the recommended Aminotadalafil dosage?
The typical dose range for Aminotadalafil is 2.5 mg - 20 mg (oral). Always start with the lowest effective dose.
How often should I take Aminotadalafil?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Aminotadalafil need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Aminotadalafil side effects?
Because aminotadalafil is assumed to behave similarly to tadalafil with the added risks of poor characterization and contamination, the side-effect profile should be considered **at least as bad as tadalafil's, with uncertain additional risks**. **PDE5-inhibitor class side effects (likely shared with tadalafil):** - Headache — the most common side effect of PDE5 inhibitors, affecting 10–15% of users - Flushing — vasodilation of cutaneous vessels, usually face and upper torso - Nasal congestion — vasodilation of nasal mucosa - Dyspepsia and gastroesophageal reflux — relaxation of the lower esophageal sphincter - Back pain and myalgia — class effect of tadalafil specifically, believed related to long half-life and PDE11 cross-reactivity - Visual disturbances — altered color perception, blue-green tinge, light sensitivity; more common with sildenafil than tadalafil, but uncertain for aminotadalafil given unknown PDE6 selectivity - Transient hearing changes — rare but reported class-wide; cases of sudden sensorineural hearing loss have been described - Dizziness and orthostatic symptoms **More serious adverse events:** - **Priapism** — prolonged painful erection lasting more than 4 hours; urologic emergency requiring immediate treatment to prevent permanent erectile dysfunction - **Non-arteritic anterior ischemic optic neuropathy (NAION)** — rare but serious; can cause permanent vision loss - **Severe hypotension**, especially in combination with nitrates, alpha-blockers, or alcohol - **Cardiovascular events** — MI, stroke, and arrhythmia have been reported, though causality in the context of pre-existing cardiovascular disease is complex **Aminotadalafil-specific concerns beyond the class:** - **Purity and contamination.** Material detected in adulterated supplements has been found to contain impurities, unknown isomers, and variable drug content within the same product batch. Forensic testing of seized supplements has documented aminotadalafil concentrations varying by an order of magnitude across capsules of the same product. - **Unknown PDE selectivity profile.** Inferior selectivity for PDE5 over PDE6 (visual side effects) and PDE11 (back pain, muscle aches) may be worse than tadalafil. - **Unknown drug-interaction profile.** Metabolic pathways and CYP interactions have not been characterized in humans. - **Combination with other adulterants.** Products containing aminotadalafil frequently also contain other undeclared pharmaceuticals, creating unpredictable interaction risks. - **Counterfeit and mislabeled products.** A "tadalafil" product from a non-legitimate channel may in fact contain aminotadalafil, sildenafil, or a mixture. **Who absolutely should not use aminotadalafil (or any PDE5 inhibitor):** - Anyone taking nitrates for angina or heart disease - Anyone taking recreational nitrates ("poppers") — the combination can cause fatal hypotension - Anyone with unstable angina, recent MI, or severe heart failure - Anyone with severe liver impairment - Anyone with severe hypotension or uncontrolled hypertension - Anyone with a history of NAION - Anyone with retinitis pigmentosa - Anyone taking ritonavir, ketoconazole, itraconazole, or other strong CYP3A4 inhibitors without dose adjustment - Anyone who has experienced priapism from prior PDE5 inhibitor use **The practical bottom line on safety:** if you have a medical indication for a PDE5 inhibitor, a licensed clinician can prescribe generic tadalafil at trivial cost. Use that route. The additional risk of consuming aminotadalafil from an unregulated supplement or bulk-research-chemical source is not justified by any benefit over the licensed drug.
Where can I buy Aminotadalafil?
Compare 1 listings from 1 vendor on our price comparison page — starting from $54.00.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.